Yoshihiko Kanno

Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

Kazem Rahimi, Zeinab Bidel, Milad Nazarzadeh et al. · The Lancet · 2021 · 299 citations · Full text

Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD

Hiromichi Suzuki, Yoshihiko Kanno, Soichi Sugahara et al. · American Journal of Kidney Diseases · 2004 · 210 citations

Hypertension, Urology, Renal Function +8

A case-control study of calciphylaxis in Japanese end-stage renal disease patients

Matsuhiko Hayashi, Ichiro Takamatsu, Yoshihiko Kanno et al. · Nephrology Dialysis Transplantation · 2011 · 195 citations · Full text

A new Classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy

Masakazu Haneda, Kazunori Utsunomiya, Daisuke Koya et al. · Journal of Diabetes Investigation · 2014 · 187 citations · Full text

Glomerular Disease, Diabetic Nephropathy 2014, Glomerulonephritis +18

Effect of Angiotensin Receptor Blockers on Cardiovascular Events in Patients Undergoing Hemodialysis: An Open-Label Randomized Controlled Trial

Hiromichi Suzuki, Yoshihiko Kanno, Soichi Sugahara et al. · American Journal of Kidney Diseases · 2008 · 183 citations

Cardiovascular Events, Hypertension, Hemodialysis +9